Lin Shao-Lee

Insider profile

Performance

Overall performance
3.1
Performance over holding periods
3.1
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 4% 68% 82%
Transactions
7 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Lin Shao-Lee's trades of Cue Biopharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
324.47
Quantity 23,294 +15.9%
Value US$3,482,772
Transaction date
Sale
Price
370.33
Quantity 83,953 -12.6%
Value US$2,387,389
Transaction date
Proposed sale
Price
134.40
Quantity 22,699
Value US$3,174,785
Transaction date
Sale
Price
29.48
Quantity 10,460 -1.5%
Value US$308,361
Transaction date
Sale
Price
28.11
Quantity 2,375 -0.3%
Value US$66,761
Transaction date
Sale
Price
27.19
Quantity 5,423 -0.7%
Value US$147,451
Transaction date
Proposed sale
Price
28.26
Quantity 18,258
Value US$515,971
Transaction date
Sale
Price
27.75
Quantity 5,775 -0.8%
Value US$160,256
Transaction date
Sale
Price
26.99
Quantity 34,225 -4.5%
Value US$923,733
Transaction date
Proposed sale
Price
27.01
Quantity 40,000
Value US$1,080,400
US ACELYRIN Inc (SLRN)
Transaction date
Sale
Price
6.63
Quantity 9,961 -0.6%
Value US$66,024
US ACELYRIN Inc (SLRN)
Transaction date
Sale
Price
7.60
Quantity 15,701 -1.0%
Value US$119,403
US ACELYRIN Inc (SLRN)
Transaction date
Planned sale
Price
7.41
Quantity 10,691 -0.7%
Value US$79,188
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-14 2026-10-12
S Sale
23,294 +15.9%
324.47
US$3,482,772 		23,294 +15.9% 324.47 US$3,482,772
2026-10-14 2026-10-12
S Sale
83,953 -12.6%
370.33
US$2,387,389 		83,953 -12.6% 370.33 US$2,387,389
2026-10-13 2026-10-12
PrS Proposed sale
22,699
134.40
US$3,174,785 		22,699 134.40 US$3,174,785
2026-08-14 2026-08-13
S Sale
10,460 -1.5%
29.48
US$308,361 		10,460 -1.5% 29.48 US$308,361
2026-08-14 2026-08-13
S Sale
2,375 -0.3%
28.11
US$66,761 		2,375 -0.3% 28.11 US$66,761
2026-08-14 2026-08-13
S Sale
5,423 -0.7%
27.19
US$147,451 		5,423 -0.7% 27.19 US$147,451
2026-08-14 2026-08-13
PrS Proposed sale
18,258
28.26
US$515,971 		18,258 28.26 US$515,971
2026-08-14 2026-08-12
S Sale
5,775 -0.8%
27.75
US$160,256 		5,775 -0.8% 27.75 US$160,256
2026-08-14 2026-08-12
S Sale
34,225 -4.5%
26.99
US$923,733 		34,225 -4.5% 26.99 US$923,733
2026-08-14 2026-08-12
PrS Proposed sale
40,000
27.01
US$1,080,400 		40,000 27.01 US$1,080,400
2024-04-03 2024-04-01
US ACELYRIN Inc (SLRN)
S Sale
9,961 -0.6%
6.63
US$66,024 		9,961 -0.6% 6.63 US$66,024
2024-02-22 2024-02-20
US ACELYRIN Inc (SLRN)
S Sale
15,701 -1.0%
7.60
US$119,403 		15,701 -1.0% 7.60 US$119,403
2024-01-04 2024-01-02
US ACELYRIN Inc (SLRN)
PlS Planned sale
10,691 -0.7%
7.41
US$79,188 		10,691 -0.7% 7.41 US$79,188